ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
8,370.00
+170.00 (2.07%)
At close: Feb 27, 2026
49.46% (1Y)
| Market Cap | 620.76B |
| Revenue (ttm) | 715.75M |
| Net Income (ttm) | -20.52B |
| Shares Out | 74.17M |
| EPS (ttm) | -306.31 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 348,171 |
| Average Volume | 690,565 |
| Open | 8,300.00 |
| Previous Close | 8,200.00 |
| Day's Range | 8,100.00 - 8,500.00 |
| 52-Week Range | 4,455.00 - 16,110.00 |
| Beta | n/a |
| RSI | 31.53 |
| Earnings Date | n/a |